Amina Abu‐Omar

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Tina Schmidt, Verena Klemis, David Schub et al. · Nature Medicine · 2021 · 344 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens

Verena Klemis, Tina Schmidt, David Schub et al. · Nature Communications · 2022 · 47 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens

Franziska Hielscher, Tina Schmidt, Verena Klemis et al. · Journal of Clinical Virology · 2022 · 37 citations · Full text

Life Sciences, Immunology, Infectious Diseases +10

Immunogenicity and reactogenicity of a heterologous COVID-19 prime-boost vaccination compared with homologous vaccine regimens

Tina Schmidt, Verena Klemis, David Schub et al. · medRxiv · 2021 · 33 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

SARS-CoV-2-specific cellular and humoral immunity after bivalent BA.4/5 COVID-19-vaccination in previously infected and non-infected individuals

Rebecca Urschel, Saskia Bronder, Verena Klemis et al. · Nature Communications · 2024 · 18 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17